✦ LIBER ✦

Management of patients with post-transplant lymphoproliferative disorder: the role of rituximab

✍ Scribed by Jakub Svoboda; Robert Kotloff; Donald E. Tsai

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab in the management of post-tran

✍ Sylvain Choquet; Stephan Oertel; Veronique LeBlond; Hanno Riess; Nathalie Varoqu 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 172 KB

Effect of Anti-CD 20 Antibody Rituximab

✍ Stephan H.K. Oertel; Erik Verschuuren; Petra Reinke; Kristin Zeidler; Matthias P 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Post-transplant lymphoproliferative diso

✍ S. Gallego; A. Llort; L. Gros; J. Sanchez de Toledo Jr; J. Bueno; A. Moreno; J. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB

Imaging of post-transplant lymphoprolife

📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 40 KB

Role of immunosuppression regimen in pos

✍ Jeffrey D. Dayton; Marc E. Richmond; Robert G. Weintraub; Anne T. Shipp; Manuela 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 352 KB

Treatment of post-transplant lymphoproli

✍ Nathan D Zilz; Lyle J Olson; Christopher G McGregor 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 78 KB